About
Male
David Donabedian is based out of Boston, Massachusetts and is the Co-Founder and Senior Advisor of Newleos Therapeutics. David previously worked at DEM Biopharma as a Co-founder, Start-up CEO and Sr. Advisor. David Donabedian attended the University of Massachusetts, Lowell.
Experience
Longwood Fund
View →Executive Partner · 2022 – present
31Boston, Massachusetts, United StatesFinance · Venture Capital
- Senior Advisor · Newleos Therapeutics2025 – present
- Co-Founder, Start-up CEO & Sr. Advisor · Solu Therapeutics2023 – present
- Director Board Of Directors · Anuncia2018 – present
- Director Board Of Directors · Anuncia Medical Inc.2018 – present
- Founding Board Member · Alcyone Therapeutics2012 – present
- Co-Founder · Newleos Therapeutics
Education
- University of North Carolina at Chapel Hill · MBA, General Management1998 – 2000
- University of Massachusetts, Lowell · Ph.D, Polymer Chemistry1988 – 1993
- Saint Anselm College · B.A, Chemistry1984 – 1988
People at Longwood Fund
Data from: crunchbase
